Cyndi Edwards @ Streetwise Live! Asks The #1 QuestionCyndi Edwards: Dr. Nutt, on a scale from 1 to 10, how hopeful are you about the possibilities with DMT and helping stroke victims?
Dr Nutt: I'm saying I'm currently at a 3, but I'm hoping once we've shown we can do it safely and started trials with patients next year, and I'm hoping I will move up to a 5 or a 6.
There's your best odds given by an expert in the field. 30% to maybe 50% or 60% given the outcome of a Phase 1 clinical trial next year. Dr. Nutt also noting that 99% of all stroke clinical trials have failed.
Meanwhile, we wait and wait and wait for the results of the IPF and Chronic Cough study that remains the best chance of success for Algernon Pharmaceuticals in the foreseeable future.
BB